Division of Cardiovascular Medicine

Sourav Panja, PhD, underwent a complicated procedure at VUMC to treat his relatively rare form of pulmonary hypertension.
September 10, 2020

Technique helped treat patient’s rare pulmonary disorder

Sourav Panja, PhD, a postdoctoral scholar in the Department of Pediatrics at Vanderbilt University Medical Center, was working in his lab one evening last year when he began coughing up blood. Even breathing was becoming difficult.

By Matt Batcheldor
July 27, 2020

Soy food, metabolism and the microbiome

Consumption of soy foods may shape the microbiome and protect against hypertension only in individuals with soy-responsive microbiota, Vanderbilt researchers have discovered.

By Sarah E. Glass
March 19, 2020

Race, hormones and diabetes risk

Variation in the levels of hormones called natriuretic peptides may contribute to racial differences in susceptibility to diabetes, suggesting that this hormone system may be a target for reducing risk of the disease.

By VUMC News and Communications
February 27, 2020

Study finds certain genetic test not useful in predicting heart disease risk

A Polygenic Risk Score — a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients — has been found not to be a useful predictive biomarker for disease risk.

By Matt Batcheldor
January 9, 2020

Interim directors of Cardiovascular Medicine named

Dan Roden, MD, and Daniel Munoz, have been named interim directors of the Division of Cardiovascular Medicine at Vanderbilt University Medical Center.

By Matt Batcheldor
December 16, 2019

Protein dynamics in the beating heart

To study the dynamics of structural proteins in the heart, Vanderbilt investigators generated a cellular tool they expect will be useful for screening drugs that affect heart muscle contraction.

By Leigh MacMillan
October 24, 2019

Wang to chair Department of Internal Medicine at UT Southwestern Medical Center

Thomas Wang, MD, director of Cardiovascular Medicine at VUMC, has been appointed chair of Internal Medicine at the University of Texas Southwestern Medical Center in Dallas, effective February 2020.
By Bill Snyder
September 19, 2019

All-in-one pill helps reduce blood pressure, cholesterol

A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study.
By Craig Boerner
August 26, 2019

VUMC investigators receive Keck Foundation award for novel atherosclerosis research

A team of researchers has received a $1 million grant from the W.M. Keck Foundation to explore a novel model of atherosclerosis development.
By Leigh MacMillan
June 20, 2019

Microbiome links diet to health

Vanderbilt researchers have discovered that the gut microbiome composition modulates how dietary nutrients are metabolized, with potential downstream consequences on metabolic health.
By VUMC News and Communications
May 9, 2019

Blueprint for rebuilding the heart

Young-Jae Nam and colleagues are discovering how to express specific factors in connective tissue cells to turn them into heart muscle cells.
By Anivarya Kumar
November 15, 2018

Benefits of smoking cessation take time: study

People who quit smoking see their risk of cardiovascular disease immediately begin to drop, but it may take up to 16 years for their health to reach the level of someone who has never smoked, according to a new Vanderbilt study.
By Matt Batcheldor
June 7, 2018

Enzyme protects against obesity-related heart disease

Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction.
By Sanjay Mishra
1 2 3 4 5